Recently registered midazolam doses for preterm neonates do not lead to equal exposure: a population pharmacokinetic model
S Völler, RB Flint, F Beggah, I Reiss… - The Journal of …, 2019 - Wiley Online Library
… developed a population pharmacokinetic model for midazolam in preterm neonates with a
… was it possible to develop a population pharmacokinetic model of this drug. Although the …
… was it possible to develop a population pharmacokinetic model of this drug. Although the …
Population pharmacokinetics of sildenafil in extremely premature infants
…, Best Pharmaceuticals for Children Act … - British journal of …, 2019 - Wiley Online Library
… In cohort 1, we obtained PK samples from infants receiving sildenafil as ordered per the local
… of sildenafil and performed PK sampling. We performed a population PK analysis and dose-…
… of sildenafil and performed PK sampling. We performed a population PK analysis and dose-…
Population pharmacokinetics and dosing optimization of amoxicillin in neonates and young infants
BH Tang, YE Wu, C Kou, YJ Qi, H Qi… - Antimicrobial agents …, 2019 - Am Soc Microbiol
… a few preterm neonates. Thus, we aimed to evaluate the population pharmacokinetics of …
size covering the entire age range of neonates and young infants and to establish evidence-…
size covering the entire age range of neonates and young infants and to establish evidence-…
Population pharmacokinetics and dosing optimization of latamoxef in neonates and young infants
H Qi, C Kou, YJ Qi, BH Tang, YE Wu, F Jin… - International journal of …, 2019 - Elsevier
… population PK in neonates and young infants (n = 128). It established an evidence-based
dosing scheme for this population using developmental PK… is optimal for population PK data …
dosing scheme for this population using developmental PK… is optimal for population PK data …
Preterm physiologically based pharmacokinetic model. Part II: applications of the model to predict drug pharmacokinetics in the preterm population
K Abduljalil, X Pan, A Pansari, M Jamei… - … Pharmacokinetics, 2020 - Springer
… PBPK models combine demographic, genetic, physiological and pathological information
in adults with in vitro data on human drug metabolism and transport to predict population PK …
in adults with in vitro data on human drug metabolism and transport to predict population PK …
Population pharmacokinetics and dose optimization of vancomycin in neonates
… pharmacokinetics of vancomycin vary among neonates, and we aimed to conduct population
pharmacokinetic … of vancomycin in Korean neonates. From a retrospective chart review, …
pharmacokinetic … of vancomycin in Korean neonates. From a retrospective chart review, …
Optimizing vancomycin dosing and monitoring in neonates and infants using population pharmacokinetic modeling
P Jarugula, A Akcan-Arikan… - Antimicrobial agents …, 2022 - Am Soc Microbiol
… a vancomycin population PK model for neonates and infants, … evaluation of vancomycin
PK in neonates and infants to our … in this study best predicts PK of our data compared to the …
PK in neonates and infants to our … in this study best predicts PK of our data compared to the …
Population pharmacokinetics of teicoplanin in preterm and term neonates: is it time for a new dosing regimen?
A Kontou, K Sarafidis, O Begou, HG Gika… - Antimicrobial Agents …, 2020 - Am Soc Microbiol
… to develop a population pharmacokinetic (PK) model in … preterm neonates. By using an
optimal design approach, a prospective PK study was designed and implemented in 60 neonates …
optimal design approach, a prospective PK study was designed and implemented in 60 neonates …
Effects of maturation and size on population pharmacokinetics of pentoxifylline and its metabolites in very preterm infants with suspected late‐onset sepsis or …
S Salman, J Hibbert, M Page‐Sharp… - British journal of …, 2019 - Wiley Online Library
… In summary, this report presents the first population pharmacokinetic model of PTX and its
principal metabolites and indicates that preterm infants' elimination capacity matures rapidly …
principal metabolites and indicates that preterm infants' elimination capacity matures rapidly …
External Evaluation of Population Pharmacokinetic Models of Piperacillin in Preterm and Term Patients from Neonatal Intensive Care
FS Boer-Pérez, V Lima-Rogel… - … and Pharmacokinetics, 2024 - Springer
… models allows us to select the most adapted model for our population [27,28,29]. … population
pharmacokinetic models for piperacillin in neonates using clinical data collected for preterm …
pharmacokinetic models for piperacillin in neonates using clinical data collected for preterm …
相关搜索
- physiologically based pharmacokinetic preterm neonates
- population pharmacokinetics of vancomycin
- young infants population pharmacokinetics
- population pharmacokinetic modeling
- population pharmacokinetics of sildenafil
- population pharmacokinetics of midazolam
- pediatric patients population pharmacokinetics
- population pharmacokinetic analysis
- population pharmacokinetics of teicoplanin
- preterm infants amoxicillin pharmacokinetics
- drug pharmacokinetics preterm population
- ampicillin in neonates population pharmacokinetics
- pre term neonates population pharmacokinetics
- neonatal infections population pharmacokinetics
- chinese children population pharmacokinetics
- dosing optimization population pharmacokinetics